Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model

Circulation

Volumn 101, Issue 25, 2000, Pages 2956-2961

  Worthley, Stephen G ^a   Helft, Gérard ^a   Fuster, Valentin ^a   Fayad, Zahi A ^a   Rodriguez, Oswaldo J ^a   Zaman, Azfar G ^a   Fallon, John T ^a,b   Badimon, Juan J ^a,c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Cardiovasc Biol Res Laboratory   (United States)

Author keywords

Arteries; Magnetic resonance imaging

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HISTOPATHOLOGY; IMAGE ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; SWINE;

EID: 0034720822     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.25.2956     Document Type: Article

References (22)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Libby P, Sukhova G, Lee RT, et al. Molecular biology of atherosclerosis. Int J Cardiol. 1997;62(suppl 2):S23-S29.
3. Fuster V, Fallon JT, Badimon JJ, et al. The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost. 1997;78:247-255.
4. Gronholdt ML, Dalager-Pedersen S, Falk E. Coronary atherosclerosis: determinants of plaque rupture. Eur Heart J. 1998;19(suppl C):C24-C29.
5. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95: 594-599.
6. Yuan C, Beach KW, Smith LH Jr, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998;98:2666-2671.
7. Worthley SG, Helft G, Fuster V, et al. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis. In press.
8. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-938.
9. Skinner MP, Yuan C, Mitsumori L, et al. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1995;1:69-73.
10. Fayad ZA, Fallon JT, Shinnar M, et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998;98:1541-1547.
11. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture, 1995. Circulation. 1996;94: 2013-2020.
12. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282.
13. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
14. Celermajer DS. Noninvasive detection of atherosclerosis. N Engl J Med. 1998;339:2014-2015.
15. Arnold JA, Modaresi KB, Thomas N, et al. Carotid plaque characterization by duplex scanning: observer error may undermine current clinical trials. Stroke. 1999;30:61-65.
16. Achenbach S, Moshage W, Ropers D, et al. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med. 1998;339:1964-1971.
17. Fiorino AS. Electron-beam computed tomography, coronary artery calcium, and evaluation of patients with coronary artery disease. Ann Intern Med. 1998;128:839-847.
18. Gallo R, Padurean A, Toschi V, et al. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation. 1998;97:581-588.
19. Edelman RR, Chien D, Kim D. Fast selective black blood MR imaging. Radiology. 1991;181:655-660.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
21. Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation. 1998;97: 946-952.
22. Archbold RA, Timmis AD. Cholesterol lowering and coronary artery disease: mechanisms of risk reduction. Heart. 1998;80:543-547.